(Q49289901)

19 February 2018

title

Genetic thrombophilia in patients with retinal vascular occlusion. (English)

1 reference

19 February 2018

1 reference

K Greiner

1

1 reference

19 February 2018

D Peetz

2

1 reference

19 February 2018

A Winkgen

3

1 reference

19 February 2018

W Prellwitz

4

1 reference

19 February 2018

N Pfeiffer

5

1 reference

19 February 2018

G Hafner

6

1 reference

19 February 2018

publication date

1 January 1999

1 reference

19 February 2018

International Ophthalmology

published in

1 reference

19 February 2018

volume

23

1 reference

19 February 2018

issue

3

1 reference

19 February 2018

page(s)

155-160

1 reference

19 February 2018

https://scigraph.springernature.com/pub.10.1023/a:1010639332737

exact match

0 references

cites work

The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions

1 reference

12 December 2020

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

1 reference

12 December 2020

Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C

1 reference

12 December 2020

[1691 G to A mutation of the factor V gene: no association with thrombosis of the central retinal vein]

1 reference

12 December 2020

Risk factors for retinal vein occlusions. A case-control study

1 reference

12 December 2020

On approximate sample sizes for comparing two independent proportions with the use of Yates' correction

1 reference

12 December 2020

Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study

1 reference

12 December 2020

Familial thrombophilia: genetic risk factors and management

1 reference

12 December 2020

Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.

1 reference

12 December 2020

World distribution of factor V Leiden

1 reference

12 December 2020

Resistance to activated protein C and risk of premature myocardial infarction

1 reference

12 December 2020

Inherited thrombophilia: Part 1

1 reference

12 December 2020

Venous thrombosis--the interaction of genes and environment

1 reference

12 December 2020

Thrombin-antithrombin III complex in acute retinal vein occlusion

1 reference

12 December 2020

Descriptive data analysis: a concept between confirmatory and exploratory data analysis

1 reference

12 December 2020

The Leiden Thrombophilia Study (LETS)

1 reference

12 December 2020

The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis.

1 reference

12 December 2020

Large-scale screening for factor V Leiden mutation in a north-eastern German population

1 reference

12 December 2020

The inherited basis of venous thrombosis

1 reference

12 December 2020

Inherited thrombophilia: Part 2

1 reference

12 December 2020

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

1 reference

12 December 2020

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

12 December 2020

Prevalence of phenotypic activated protein C resistance (APCR) in venous thromboembolic patients

1 reference

12 December 2020

Prevalence of factor V Leiden in young adults with retinal vein occlusion

1 reference

12 December 2020

Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain.

1 reference

12 December 2020

Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors--correlation with absence of Arg506-Gln mutation of factor V gene

1 reference

12 December 2020

Coagulation factor V Leiden mutation may have a racial background.

1 reference

12 December 2020

Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction

1 reference

12 December 2020

No association of APC resistance with myocardial infarction.

1 reference

12 December 2020

Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion

1 reference

12 December 2020

A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

1 reference

12 December 2020

Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion

1 reference

12 December 2020

The Natural Course of Central Retinal Vein Occlusion

1 reference

12 December 2020

Modified test for activated protein C resistance.

1 reference

12 December 2020

Activated protein C resistance in young adults with central retinal vein occlusion

1 reference

12 December 2020

Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women

1 reference

12 December 2020

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

1 reference

12 December 2020

Does type II diabetes predispose to retinal vein occlusion?

1 reference

12 December 2020

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

1 reference

12 December 2020

Hypercoagulability and high lipoprotein(a) levels in patients with central retinal vein occlusion

1 reference

12 December 2020

Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease

1 reference

12 December 2020

Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1010639332737

1 reference

19 February 2018

Dimensions Publication ID

1048153112

0 references

1 reference

19 February 2018